Eagle Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex…

Drug Manufacturers - Specialty & Generic
US, Woodcliff Lake [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Eagle Pharmaceuticals, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of EGRX's Analysis
CIK: 827871 CUSIP: 269796108 ISIN: US2697961082 LEI: - UEI: -
Secondary Listings
EGRX has no secondary listings inside our databases.